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VEGFVascular endothelial growth factor (VEGF) is the growth factor responsible for the triggering of angiogen-
esis, the process of blood vessel formation supporting the long-term viability of any repaired or regener-
ated tissue. As the growth factor is effective only when concentration gradients are generated, new
shuttles need to be developed that ensure both the control of gradients at the site of tissue repair and
the release of VEGF at physiological levels. Magnetic hyperthermia is the production of heat induced
by magnetic materials through their exposure to an external oscillating magnetic field. In this paper,
magnetic nanoparticles capable of generating controllable hyperthermia were functionalised with hyper-
branched poly(epsilon-lysine) peptides integrating in their core parallel thermoresponsive elastin-like
peptide sequences and presenting an uppermost branching generation tethered by the zwitterionic
amino acid carboxybetaine. The results show that these functionalised magnetic nanoparticles avidly
bind VEGF and release it only upon generation of mild-hyperthermic pulses generated by oscillating mag-
netic filed. The VEGF release occurred in a temperature range at which the elastin-like peptides collapse.
It is proposed that, through the application of an external magnetic field, these magnetic carriers could
generated gradients of VEGF in vivo and allow its tuned delivery in a number of clinical applications.
Statement of Significance
The present paper for the first time reveals the possibility to control the delivery of VEGF through mild
hyperthermia stimuli generated by a oscillating magnetic field. To this purpose, magnetic nanoparticles
of high size homogeneity and coated with a thin coating of poly(acrylic acid) were functionalised with a
novel class of poly(epsilon lysine) dendrimers integrating in their structure a thermoresponsive amino
acid sequence mimicking elastin and exposing at high density a zwitterionic modified amino acid, the
carboxybetaine, known to be able to bind macromolecules. Physicochemical and biochemical character-
isation elegantly show the link between the thermal properties of the nanoparticles and of the dendrimer
change of conformation and how this enable the release of VEGF at temperature values compatible with
the growth factor stability.
 2016 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CCBY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Physiological angiogenesis is a key factor in any therapy
aiming at the long-term viability of any regenerated of tissues[1]. Vascular endothelial growth factor (VEGF) is known to be the
growth factor initiating this process and its delivery into the dam-
aged tissue area has been proposed to stimulate the sprouting of
new blood vessels from the surrounding healthy tissue [2]. As
VEGF stimulates angiogenesis through very controlled concentra-
tion gradients, it is widely recognised that any therapeutic
approach based on its administration need to be coupled with its
spatiotemporal control [3]. It has been hypothesized that magnetic
carriers of VEGF could indeed be injected into tissue with a
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could be driven by an external magnetic field capable of distribut-
ing the VEGF as a controlled gradient [4]. Indeed, the controlled
transport of magnetic nanoparticles in vivo along a magnetic field
has already been demonstrated [5]. Still, in the case of a growth
factor-based therapy, the transport of VEGF in a gradient fashion
need to be accompanied by its controlled delivery to the target
endothelial cells. Magnetic hyperthermia is the production of heat
induced by magnetic materials through their exposure to an exter-
nal oscillating magnetic field. The transformation of radio-
frequency (RF) magnetic energy into heat by super-paramagnetic
nanoparticles (SPM-MNP) has been attributed to Néel and Brown
relaxation mechanisms occurring in single-domain super-
paramagnetic materials [6]. It is accepted that Néel relaxation
(inner fluctuation of the magnetic moment) and Brown relaxation
(rotation of the whole particle) are the magnetic loss mechanisms
responsible for the heating power of SPM-MNP in a solvent and are
characterised by different magnetic relaxation times, sN and sB,
respectively. The efficiency of the whole set-up to transform the
external magnetic energy into heat depends on both instrumental
parameters (externally applied magnetic field intensity and fre-
quency) and physico-chemical properties of the colloidally-stable
nanosized systems (particle size and distribution, shape, solvent
and magnetic properties of nanoparticles) [7–9]. These optimized
systems have been proposed for different fields of applications
including electronics, energy and biomedicine. In biomedicine,
hyperthermia has mainly been used for cancer therapy through
the localised generation of relatively high temperature [10–17],
but its application in controlled signalling and bioactive molecule
release has yet to be exploited.
Recently, colloidal suspensions of iron oxide SPM-MNPs coated
with polyacrylic acid (PAA), suspended in liquids of different vis-
cosities and concentrations, have been studied in the attempt of
optimizing the conditions necessary to generate hyperthermia in
biomedical applications [18]. Hyperbranched molecules such as
dendrimers and dendrons, based on organic molecules, saccha-
rides, amino acids or combinations thereof have previously been
proposed for use in a number of biomedical applications [19]. Here,
hyperbranched peptides based on core lysine monomers have been
designed to bear a tree-like molecular structure (dendrons); (i) the
root of the dendron allows the covalent grafting to poly(acrylic
acid)-coated SPM-MNP iron oxide nanoparticles (Fe3O4@PAA), (ii)
the first generation of branching is able to undergo multiple ther-
mal transition in the range 25–42 C and (iii) an uppermost
branching generation is able to reduce MNP aggregation and facil-
itate the binding with bioactive molecules such as the vascular
endothelial growth factor (VEGF), a growth factor playing a key
role in stimulating angiogenesis, i.e. blood vessel sprouting [20].
Evidence of the thermoresponse of the grafted dendrons upon
magnetic hyperthermia is provided alongside a demonstration of
VEGF release in physiological buffer.2. Materials and methods
2.1. Dendron synthesis
Poly (e-lysine) dendrons of three (G3K) branching generation
type were synthesised on a Tenta Gel S (ANH2) resin (Iris Biotech
GmbH, Germany) using a 9-fluorenylmethoxycarbonyl (Fmoc)
solid phase peptide method (Fig. 1). Dendrons were designed
with a cysteine as core molecule. The resin was placed inside a
reaction vessel and swollen in N,N-dimethylformamide (DMF)
(Fisher Scientific UK) for 15 min. After washing with 3  7 cm3
DMF, the addition of an acid labile Rink amide linker (Iris Biotech
GmbH, Germany) to the resin was undertaken via the C-terminalof the linker. The Rink amide linker was added in a fourfold molar
excess in 3 cm3 of DMF in addition to which was added the acti-
vation agents, 0.45 M O-Benzotriazole-N,N,N0,N0-tetramethyl-uro
nium-hexafluoro-phosphate (HBTU) (Novabiochem, UK) and
140 lL N,N-diisopropylethylamine (DIPEA) (Sigma Aldrich Co.
Ltd, UK). The coupling reaction was allowed to proceed for
30 min at room temperature. The reaction mixture was expelled
from the syringe and the contents of the reaction vessel were
then was then washed three times with 7 cm3 of DMF. The
base-labile Fmoc-group was removed using 20% v/v piperidine
(Sigma Aldrich Co. Ltd, UK) in DMF in a series of deprotection
steps at room temperature for 2 min, followed by washing with
3  7 cm3 DMF. This procedure was repeated twice more. The
exposure of N-terminal amine allowed the assembly of the estab-
lished Fmoc-amino acids sequence. After the amino acid sequence
were added using the coupling and deprotection steps outlined
above, the peptide was allowed to stand for 30 min for a final
deprotection step in 20% v/v piperidine (Sigma Aldrich Co. Ltd,
UK) in DMF and washed with 3  7 cm3 DMF. The contents of
the reaction vessel were then washed with 40 cm3 dichloro-
methane (Fisher Scientific, UK), methanol (Fisher Scientific, UK)
and diethylether (Fisher Scientific, UK). Then, the product of syn-
thesis was dried and weighed prior to be cleaved from the resin.
Fmoc-protected groups of 50 mg dendrons were removed using
two distinct mixture (i) 94% v/v trifluoroacetic acid (TFA) (Fisher
Scientific, UK), 2.5% v/v deionised H2O, 1% v/v 1–2 ethanedithiol
(EDT) (Acros Organics, UK) and 2.5% v/v triisopropylsilane (TIPS)
(Sigma Aldrich Co. Ltd, UK) and (ii) 88% v/v TFA, 5% v/v deionised
H2O, 5% w/v phenol (Sigma Aldrich Co. Ltd, UK) and 2% v/v TIPS at
room temperature. All cleavage mixtures were prepared fresh
prior to use. After three hours incubation, the solution was passed
down a Pasteur pipette filled with 1 cm of a glass wool and the
crude peptide was collected in a tube containing 20 cm3 of chilled
diethylether. The solution was then centrifuged (Denley BS400) at
3500 rpm for 5 min to collect the dendron. The diethylether was
then carefully decanted from the tube and fresh diethylether
20 cm3 was added and the sample was vortexed to disrupt the
peptide pellet. The centrifugation procedure was then repeated
twice more and the diethylether was subsequently decanted off.
The reaction product was then freeze dried (Christ Alpha2-4), dis-
solved in ethanol and filtered through a syringe filter with a pore
diameter of 0.22 lm (GE Healthcare Amersham, UK) prior to
characterisation.2.2. Dendron characterisation
Once synthesised the dendron was characterised by analytical
HPLC to determine purity and further purified by further by
preparative HPLC. The crude peptide was separated by a standard
analytical HPLC method (WatersTM 717 plus Autosampler) per-
formed on a hydrophobic RP 18 column (150  4.60 mm, Luna 3u
C18 100A, Phenomenex) at 25 C (Column chiller Model 7955,
Jones Chromatography). The mobile phase consisted of a stepwise
gradient of two solvent systems (Solvent A deionised water with
0.1% v/v TFA, Solvent B acetonitrile with 0.1% v/v TFA). Chro-
matograms were recorded on UV detector (SPO-6A, Shimadzu)
and analysed by HPLC software, Total Chrom-TC Navigator. Micro-
TOF mass spectrometry was used to characterise the dendron. The
dendron once cleaved from the resin was dissolved in methanol
(1 mg/mL) and the sample was analysed using a microTOF mass
spectrometer (Bruker) with electron spray ionisation in positive
ion mode. The range analysed was from 50 to 3000m/z and frag-
ments produced were analysed using Bruker Daltonics Data Anal-
ysis 3.4.
Fig. 1. Schematic representation of the solid phase synthesis of C-ELP-G3K-Bet16.
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characterisation
Fe3O4@PAA were synthesized as previously reported [21].
Briefly, the iron oxide nanoparticles were synthesized by co-
precipitation of an aqueous solution containing a stoichiometric
amount of Fe2+ and Fe3+ salts with ammonium hydroxide (NH4OH,
28%). The PAA was added in molar excess to the nanoparticle dis-
persion. The PAA coating has twofold effects: a) to increase the
aqueous colloidal stability and b) to leave at the nanoparticle sur-
face carboxyl functional groups susceptible of being further func-
tionalized. As previously reported [21], the average particle size
measured by transmission electron microscopy analysis resulted
to be around 10 nm of diameter. XRD data (not shown) confirmed
a single phase with a very good crystallinity, whereas the hystere-
sis loops measured in a VSM showed superparamagnetic behavior
with no remanence or coercivity at zero-field and saturation mag-
netization as high as 60 emu/g, which is a very high value for such
small NPs (data not shown).
Fe3O4@PAA (13 mg) were washed three times with 20 ml of
ethanol. A 20 ml volume of 0.1 M MES buffer containing 38 mg
EDC and 6 mg NHS was added, the solution was vortexed for 30 s
and then placed in the shaking incubation for 30 min. L-cysteine
(25 mg, 0.2 mmole) was added and the mixture was shaken for
1 h. The MES buffer was removed and the beads washed three
times with ethanol. The beads were then split into two tubes. To
conjugate the dendrimers to the cysteine via a disulfide bridge,
10 ml 8 M urea containing 3% w/v hydrogen peroxide were added
along with (i) 5.3 mg, 1 lmole ELP dendrimer and (ii) 3 mg,
1 lmole of C-ELP-G3K-Bet16 dendrimer. The tubes were then
returned to the shaking incubator for 30 min. Scanning electron
microscopy analysis was performed by a FEG-SEM Zeiss SIGMA
at 5 keV on palladium-coated specimens. The SEM analysis was
considered important to rule out any significant alteration of mor-
phology and/or size of the particles after their treatment with the
coupling reagents. DSC was performed twice at heating rate of
10 C/minute, over the range 50 to 50 C using a Mettler Toledo
DSC 1 and STARe Thermal analysis software. Thermal transitions
were studied in the 25 C to 50 C.
2.4. Uploading of VEGF and its release from Fe3O4@PAA-C-ELP-G3K-
Bet16
Fe3O4@PAA-C-ELP-G3K-Bet16 were re-suspended at 1 mg/ml in
1.25 ng to 30 lg/ml hVEGF (Abcam, UK) and incubated at 25 C
for 2 h under orbital shaking 100 rpm. The MNPs were then pel-
leted by centrifugation at 3500 rpm for 25 min. Excess supernatant
was removed and stored for analysis by ELISA. Fe3O4@PAA-C-ELP-
G3K-Bet16 were then washed with 2 ml of ethanol and centrifuged
as previously described. The supernatant was collected and anal-
ysed by ELISA. Fe3O4@PAA-C-ELP-G3K-Bet16 were then resus-
pended in ethanol and added to Eppendorf tubes and allowed to
air dry in a glove box at 20 C.
Magnetic hyperthermia characterisations were performed by
the means of a magnetic RF power generator operating at a fre-
quency of f = 293 kHz and an induced magnetic field of
B = 30 mT. These mild hyperthermia conditions increased signifi-
cantly the temperature around the nanoparticle and induced a con-
formational change in the elastin moieties in a relatively short
period of time to reduce any risk of significant VEGF denaturation
induced by the induced temperature values that are relatively
higher (up to 43 C) than physiological body temperature. The
samples were introduced in cylindrical Teflon sample holder and
placed in the mid-point of an ethylene glycol cooled hollow coil
(maximum of the RF magnetic field), inside a thermally isolated
cylindrical Dewar glass maintained under high vacuum conditions(106 mbar). The Teflon sample holder allows the insertion of an
optic–fibre thermometer tip to monitor and record the magnetic
hyperthermia response (temperature increase) versus time during
the application of the magnetic field.
Dried samples of Fe3O4@PAA-C-ELP-G3K-Bet16-VEGF were, first,
dispersed in PBS by using an ultrasonic bath with a mixture of ice
and water, in order to obtain a well-dispersed ferrofluid and to
avoid the premature release of VEGF by ultrasound energy heating.
Then, inductive heating was applied to Fe3O4@PAA and Fe3O4@-
PAA-C-ELP-G3K-Bet16 – VEGF ferrofluid samples with the same
magnetite concentration and volume, in order to obtain a temper-
ature increase compatible with VEGF release (above 42 C).
Accordingly to the intricate parametric dependencies of magnetic
hyperthermia responses, the experimental procedure was carefully
designed to optimize the magnetic heat production and to preserve
the complex Fe3O4@PAA-C-ELP-G3K-Bet16 in perfect conditions
along the whole process. Therefore, from prior studies [14], the
mass of Fe3O4@PAA-C-ELP-G3K-Bet16-VEGF sample 10 mg and vol-
ume of solvent PBS 240 lL, were chosen to obtain a ferrofluid with
adequate concentration, 40 mg/mL, assuring an optimal magnetic
hyperthermia response (42 C in a few minutes) that is below the
accepted denaturation point for proteins like VEGF.
During the hyperthermia experiment, VEGF charged sample
was carefully monitored to avoid overheating, switching it off
when the sample temperature arrived to 42 C. Finally, the super-
natant containing the released VEGF was collected after 25 min of
soft centrifugation at 3500 rpm to further proceed with ELISA char-
acterisation. Released VEGF was tested by ELISA kit (R&D Systems).2.5. Statistical analysis
ELISA data of VEGF release were analysed by ANOVA t test. Data
were considered significantly different at p 6 0.01 from n = 6.3. Results
Poly(epsilon-lysine) dendrons with three generations of
branching (G3) were obtained by solid-phase peptide synthesis.
The molecular design of these dendrons included a core bi-
peptide made of cysteine (Cys) and lysine (Lys) forming the root
(G0) of the molecular tree. The alpha and epsilon amino groups
of the lysine were exploited to assemble additional Lys to form
the first generation of branching (G1). The linear pentapeptide
(Val-Pro-Gly-Val-Gly), that is known to undergo thermal transition
in the range of temperature 25–42 C [22–26], was then assembled
onto each of the four available exposed amino group. The four pen-
tapeptide sequences were extended by the addition of a Lys mono-
mer that allowed the branching of the macromolecule into a
second generation (G2). The third branching generation (G3) was
then assembled to expose 16 primary amine groups at the outer-
most terminal branches. These were finally tethered with units
of carboxybetaine (Bet), a modified amino acid (i.e. trimethyl gly-
cine), that is known to facilitate the structuring of water around
its functionalities [27]. The resulting dendron [Cys-Lys-Lys2-(Val-
Pro-Gly-Val-Gly-Lys)4-(Lys)8-(Bet)16] (i.e. C-ELP-G3K-Bet16) was
purified by preparative HPLC (single elution peak at 14.2 min)
and characterised by analytical HPLC and mass spectrometry
[MS, peaks (M + H)3+ = 1798, (M + H)5+ = 1079, (M + H)6+ = 896]
confirming the synthesis of the molecule at a degree of purity
higher than 95% and in batches higher than 55 mg.
Purified thermoresponsive dendrons were conjugated to the
PAA-SPM-MNP (Fig. 2a) that by dynamic light scattering showed
a diameter of 18.46 nm, a polydispersity index of 0.331 and a zeta
potential of 45.6 mV (Fig. 2b).
Fig. 2. Dynamic light scattering (a) Fe3O4@PAA-C-ELP-G3K-Bet16 and (b) Fe3O4@PAA.
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obtained through the formation of a disulfide bond. This was
obtained by the grafting of monomers of Cys to the PAA surface
of the nanoparticles the carboxylic groups of which were previ-
ously activated by mild etching in 0.1 M NaOH. The binding of
the thermoresponsive dendron through its Cys root was then com-
pleted to obtain Fe3O4@PAA-C-ELP-G3K-Bet16 of 33.37 nm in diam-
eter, a reduced zeta potential of 25.6 mV and improved
polydispersity index of 1.000 (Fig. 2a and b). Scanning electron
microscopy (SEM) before and after surface functionalisation
demonstrated that dendrons were able to change the topographi-
cal features of the nanoparticle surface, an electron-translucent
layer always forming a contour around the nanoparticles that
appeared more discrete even in the dry conditions determined by
the analytical conditions (Fig. 3a and b).
The thermoresponsive properties of the unmodified and
dendron-functionalised nanoparticles were studied by dynamicFig. 3. Scanning electron microscopy (SEM) of Fe3O4@PAA (A and B) – Fe3O4@PAA-C-ELP
coating. Magnification bars in (a) and (b): 100 nm. Magnification bars in (c) and (d): 20scanning calorimetry (DSC) and in magnetic hyperthermia condi-
tions. DSC of the Fe3O4@PAA-C-ELP-G3K-Bet16 was first performed
in the range of temperature at which ELP peptides are known to
undergo reversible transition to reach the threshold at which the
irreversible molecular collapsing takes places (Fig. 4a). The DSC
scan showed a first endothermic onset at 27 C and a peak of heat
absorption at 31.4 C, which has previously been observed as the
inverse temperature transition in poly pentapeptide elastin-
based sequences [25]. Two additional peaks at 35.1 C and at
43.5 C followed. The first three thermal transitions correspond
to those reported in literature for the linear ELP peptide and attrib-
uted to a constant oscillation of the molecule [22–26]. The transi-
tion occurring at the highest temperature value (43.5 C) has being
identified as the value at which the molecule undergoes irre-
versible collapsing caused by hydrophobic association of the ELP
sequence, resulting in the expulsion of bound water molecules
[26]. A second scan was then performed in the same range of-G3K-Bet16-VEGF (C and D), arrows indicate the presence of an electron translucent
nm.
Fig. 4. Differential scanning calorimetry. First run of Fe3O4@PAA-C-ELP-G3K-Bet16 from 50 to 50 C at a heating rate of 10 C/min (a). A series of transitions were observed in
the range 25 to 45 C of the first run performed (b). The sample was then cooled to 50 C and a second run performed over the same range of temperature to confirm the
irreversible collapsing of the grafted dendrons (c). Here only one major thermal transition was observed at 35 C (d).
Fig. 5. Hyperthermia Treatment of Fe3O4@PAA and Fe3O4@PAA-C-ELP-G3K-Bet16
samples with a volume of 240 (lL) and a magnetite concentration of 40 (g/L). These
data were achieved by the monitoring of the magnetic hyperthermia developed by
Fe3O4@PAA and Fe3O4@PAA-C-ELP-G3K-Bet16 when immersed in phosphate
buffered saline pH 7.4. The unmodified Fe3O4@PAA showed to produce a smooth
increase of temperature values upon exposure to the alternating current magnetic
field, whereas the Fe3O4@PAA-C-ELP-G3K-Bet16 clearly showed heat absorption at
the same temperature values observed by DSC (Fig. 5, arrows). Temporary
temperature plateaus were observed in the ranges 26–27 C, 29–33 C (Black box,
temperature of elastin-like peptide oscillation shown as red coil in the Fe3O4@PAA-
C-ELP-G3K-Bet16 cartoon) and 37–40 C (Red box, temperature close to the known
elastin-like peptide collapsing, black coil in the Fe3O4@PAA-C-ELP-G3K-Bet16
cartoon). (For interpretation of the references to color in this figure legend, the
reader is referred to the web version of this article.)
240 S.T. Meikle et al. / Acta Biomaterialia 40 (2016) 235–242temperature to confirm the irreversible collapsing of the grafted
dendrons (Fig. 4b). In this case, only one major thermal transition
was observed at 35 C.
These data were corroborated by the monitoring of the mag-
netic hyperthermia developed by Fe3O4@PAA and Fe3O4@PAA-C-
ELP-G3K-Bet16 when immersed in phosphate buffered saline, pH
7.4. The unmodified Fe3O4@PAA showed to produce a regular
increase of temperature values upon exposure to the alternating
current magnetic field, whereas the Fe3O4@PAA-C-ELP-G3K-Bet16
clearly showed heat absorption at the same temperature values
observed by DSC (Fig. 5, arrows). Indeed, temporary temperature
plateaus were observed in the ranges 26–27 C, 29–33 C, 39–
40 C and 42.5 C. Both samples reached the desired temperature
increase, although large differences in the heating rate and the
final temperature magnitude are observed which can be attributed
to the role of the polymer coating [13]. The coating stabilizes the
SPM in the solvent, not only by balancing inter-particle dipolar
interactions, exchange contact interactions or electrostatic forces,
but also through changes in the hydrodynamic radius that controls
the Brownian relaxation time [6]. Therefore, the differences in
coating width and composition for the PAA and PAA-C-ELP-G3K-
Bet16-VEGF coated samples are behind their hyperthermia perfor-
mance in concordance with similar ferrofluids previously reported
[6].
VEGF binding on Fe3O4@PAA-C-ELP-G3K-Bet16 was optimized to
achieve a maximum loading of hVEGF of 3.64 lg/mg of Fe3O4@-
PAA-C-ELP-G3K-Bet16. The VEGF-laden magnetic shuttles were
tested under the same magnetic field conditions used to study mild
magnetic hyperthermia. Fig. 6 shows that no release of VEGF was
observed at the middle temperature transition point that is also
the body temperature and a release of 35 ng/ml corresponding
approximately to 18% of the bound VEGF was achieved when
hyperthermia overcame the temperature value at which the den-
dron undergoes molecular collapsing (43 C). It is suggested that
the loss of water molecules occurring in the dendron at this tem-
perature threshold would lead to the collapse of the molecular
structure and the consequent release of the growth factor at ther-apeutic concentrations. There was no complete release of the
bound VEGF that may suggest the need for a more extended expo-
sure of the carriers to the alternating magnetic field to ensure col-
lapsing of all the dendrons. Alternatively, it could be speculated
that part of the VEGF molecules have been denaturated by the
thermal pulse and that the relative conformational change does
not allow antibody recognition during the ELISA assay.
Fig. 6. Release of hVEGF from Fe3O4@PAA-C-ELP-G3K-Bet16-VEGF after hyperther-
mia treatment. Negative control shows no hVEGF release after hyperthermia
treatment.
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The engineering of biocompatible systems able to trigger struc-
tural and conformational changes under certain physicochemical
stimuli has been widely considered for therapeutic applications
in regenerative medicine. In particular, nanostructures containing
magnetic components are very attractive as they allow
minimally-invasive, in situ stimulation of tissues by an external
magnetic field [28]. An oscillating magnetic field can induce a tem-
perature increase around the magnetic nanoparticle called mag-
netic hyperthermia. The main advantage of this thermal effect
has so far demonstrated in cancer therapy where localised, high
temperature heating allows the target-specific death of tumor cells
and avoid the secondary cytotoxic effects derived from conven-
tional chemotherapy treatments [28]. In this paper, a mild mag-
netic hyperthermia was pursued for regenerative medicine
purposes rather than for the disruption of tumoral masses. The
application of an external magnetic field capable of generating
hyperthermia in target tissues through injected MNP carriers of
bioactive molecules is a very attractive approach in any personal-
ized treatment where different doses of the pharmaceutical sub-
stance need to be administered in situ on the basis of the
patient’s clinical conditions [28]. In addition, these magnetic
nanostructures could allow a theranostic approach where the mag-
netic core of the carrier could provide contrast enhancement in
magnetic resonance imaging of the damaged tissue during its
phases of repair. More recently, biocompatible magnetic scaffolds
have been reported to be able to generate magnetic field fluxes
and gradients around and within their porosity through
externally-applied magnetic fields [29,30]. Therefore, magnetic
carriers for controlled growth factor delivery could be coupled
with these scaffolds to support their rapid vascularization.
In the present paper, the proof of concept was focused on the
potential of using mild magnetic hyperthermia for the controlled
release of VEGF, a key growth factor in the stimulation of angiogen-
esis [2]. Unique to this work is the use both of super paramagnetic
nanoparticles able to generate mild hyperthermia and of peptidic
dendrons capable of changing conformation at those mild hyper-
thermia conditions. The physicochemical properties of the
nanoparticles allowed the high-precision control of hyperthermia
in very short ranges of time (seconds) thus avoiding any significant
growth factor denaturation. The design of a class of hyperbranched
peptidic dendrons able to (i) bind VEGF through the well-known
properties of a zwitterionic molecule, the carboxybetaine, in pre-serving the bioavailability of bioactive compounds [27] and (ii)
respond to the mild hyperthermia generated by the magnetic
nanoparticles by the irreversible collapsing of its branched struc-
ture led to the release of the growth factor at therapeutic levels.
The hyperthermia parameters fulfilled the biochemical safety rec-
ommendations for the use of magnetic hyperthermia in clinical
applications that have been identified in the range of radiofre-
quency between several hundreds of kHz and 1 MHz within the
electromagnetic spectrum. Therefore, the hyperthermia experi-
ments have been designed to be into the safety specific absorption
range (SAR) range for in vivo applications H f < 4.58108 (Am1-
s1) [18]. Harmful secondary effects, such as abrasions and burns,
can be caused in healthy tissues outside this range [18].
Beside this main achievement, the paper has also been able to
demonstrate that the functionalisation of the magnetic nanoparti-
cles with macromolecules presenting high density carboxybetaine
was also able to reduce their tendency to aggregation, a problem
related to all types of nanoparticles. This was attributed to the
highly hydrophilic character of carboxybetaine that is believed to
form a hydration shell preventing aggregation processes [27].
Unlike previous works where the ELP peptides have shown a sig-
nificant thermoresponsiveness only when integrated in polymers
of relatively high molecular weight, the present work suggests that
their integration in an orderly parallel structure at the first branch-
ing generation of the dendron has amplified their property to make
it exploitable for the purpose of growth factor release even if part
of a relatively small macromolecule.5. Conclusions
Despite the recognised therapeutic potential of growth factors
in regenerative medicine, their application in clinics is still limited
by the ability of controlling their delivery in a precisely localised
manner and at effective and yet safe doses. Multiple doses are also
desirable to stimulate the tissue at different stages of its repair
mechanism, but these are usually administrated through repeated
injections causing patients distress and reduced accuracy of deliv-
ery. The magnetic nanodevice presented in this work has shown
ideal properties to fulfil all the main clinical requirements for VEGF
release. First of all, the reduced tendency to aggregation of the
dendron-functionalised NMP, supported by the improved polydis-
persity index, improves their potential use in biomedical applica-
tions as it ensures the dispersion of the nanoparticles that is a
pre-requisite for the optimization of the VEGF binding without
the use of toxic surfactants. Moreover, these newmagnetic shuttles
can be delivered to the targeted tissue through the drive of a mag-
net to maximise their localisation at the site of regeneration and a
gradient can be generated exploiting the lines and forces of the
magnetic field. Once localised, the VEGF release could be controlled
by pulses of mild hyperthermia to induce angiogenesis at a rate
that is tuned with that of the repairing tissue.
Acknowledgement
This work was funded as part of EC project MAGISTER contract
Number NMP3-LA-2008-214685.
References
[1] M.M. Martino, S. Brkic, E. Bovo, M. Burger, D.J. Schaefer, T. Wolff, L. Gürke, P.S.
Briquez, H.M. Larsson, R. Gianni-Barrera, J.A. Hubbell, A. Banfi, Extracellular
matrix and growth factor engineering for controlled angiogenesis in
regenerative medicine, Front. Bioeng. Biotechnol. (2015), http://dx.doi.org/
10.3389/fbioe.2015.00045.
[2] A. Hoeben, B. Landuyt, M.S. Highley, H. Wildiers, A.T. Van Oosterom, E.A. De
Bruijn, Vascular endothelial growth factor and angiogenesis, Pharmacol. Rev.
56 (4) (2004) 549–580.
242 S.T. Meikle et al. / Acta Biomaterialia 40 (2016) 235–242[3] Y. Brudno, A.B. Ennett-Shepard, R.R. Chen, M. Aizenberg, D.J. Mooney,
Enhancing microvascular formation and vessel maturation through temporal
control over multiple pro-angiogenic and pro-maturation factors, Biomaterials
34 (2013) 9201–9209.
[4] A. Banfi, G. Von Degenfeld, R. Gianni-Barrera, S. Reginato, M.J. Merchant, D.M.
McDonald, H.M. Blau, Therapeutic angiogenesis due to balanced single-vector
delivery of VEGF and PDGF-BB, FASEB J. 26 (2012) 2486–2497.
[5] Y. Zhang, W. Li, L. Ou, W. Wang, E. Delyagina, C. Lux, H. Sorg, K. Riehemann, G.
Steinhoff, N. Ma, Targeted delivery of human VEGF gene via complexes of
magnetic nanoparticle-adenoviral vectors enhanced cardiac regeneration, PLoS
ONE 7 (7) (2012) e39490.
[6] R. Hergt, W. Andra, C.G. d’Ambly, I. Hilger, W.A. Kaiser, U. Richter, H.-G.
Schmidt, Physical limits of hyperthermia using magnetite fine particles, IEEE
Trans. Magn. 34 (1998) 3745–3754.
[7] J.P. Fortin, C. Wilhelm, J. Servais, C. Me´nager, J-C Bacri, F. Gazeau, Size-sorted
anionic iron oxide nanomagnets as colloidal mediators for magnetic
hyperthermia, JACS 129 (2007) 2628–2635.
[8] M. Lévy, C. Wilhelm, J.-M. Siaugue, O. Horner, J.-C. Bacri, F. Gazeau,
Magnetically induced hyperthermia: size-dependent heating power of c-
Fe2O3 nanoparticles, J. Phys.: Condens. Matter 20 (2008) 204133.
[9] M. Gonzales-Weimuller, M. Zeisberger, K.M. Krishnan, Size-dependant heating
rates of iron oxide nanoparticles for magnetic fluid hyperthermia, J. Magn.
Magn. Mater. 321 (2009) 1947–1950.
[10] A.S. Eggeman, S.A. Majetich, D. Farrell, Q.A. Pankhurst, Size and concentration
effects on high frequency hysteresis of iron oxide nanoparticles, IEEE Trans.
Magn. 43 (2007) 2451–2453.
[11] A. Jordan, R. Scholz, P. Wust, H. Fähling, R. Felix, Magnetic fluid hyperthermia
(MFH): cancer treatment with AC magnetic field induced excitation of
biocompatible superparamagnetic nanoparticles, J. Magn. Magn. Mater. 201
(1999) 413–419.
[12] M.W. Dewhirst, B.L. Viglianti, M. Lora-Michiels, M. Hanson, P.J. Hoopes, Basic
principles of thermal dosimetry and thermal thresholds for tissue damage
from hyperthermia, Int. J. Hyperthermia 19 (2003) 267–294.
[13] M. Mahmoudi, S. Sant, B. Wang, S. Laurent, T. Sen, Superparamagnetic iron
oxide nanoparticles (SPIONs): development, surface modification and
applications in chemotherapy, Adv. Drug Deliv. Rev. 63 (2011) 24–46.
[14] C.S.S.R. Kumar, F. Mohammad, Magnetic nanomaterials for hyperthermia-
based therapy and controlled drug delivery, Adv. Drug Deliv. Rev. 63 (2011)
789–808.
[15] S.-H. Hu, B.-J. Liao, C.-S. Chiang, P.-J. Chen, S-Y. Chen, I-W. Chen, Core-shell
nanocapsules stabilized by single-component polymer and nanoparticles for
magneto-chemotherapy/hyperthermia with multiple drugs, Adv. Mater. 24
(2012) 3627–3632.
[16] T-J. Li, C.-C. Huang, P.-W. Ruan, K.-Y. Chuang, K.-J. Huang, D.-B. Shieh, C.-S. Yeh,
In vivo anti-cancer efficacy of magnetite nanocrystal - based system using
locoregional hyperthermia combined with 5-fluorouracil chemotherapy,
Biomaterials 34 (2013) 7873–7883.[17] J.A. Barreto, W. O’Malley, W.M. Kubeil, B. Graham, H. Stephan, L. Spiccia,
Nanomaterials: applications in cancer imaging and therapy, Adv. Mater. 23
(2011) H18–H40.
[18] S. Mornet, S. Vasseur, F. Grasset, E. Duguet, Magnetic nanoparticle design for
medical diagnosis and therapy, J. Mater. Chem. 14 (2004) 2161–2175.
[19] S. Svenson, D.A. Tomalia, Dendrimers in biomedical applications—reflections
on the field, Adv. Drug Deliv. Rev. 57 (2005) 2106–2129.
[20] J. Street, M. Bao, L. deGuzman, S. Bunting, F.V. Peale Jr., N. Ferrara, H. Steinmetz,
J. Hoeffel, J.L. Cleland, A. Daugherty, N. van Bruggen, H.P. Redmond, R.A.D.
Carano, E.H. Filvaroff, Vascular endothelial growth factor stimulates bone
repair by promoting angiogenesis and bone turnover, PNAS 99 (2002) 9656–
9661.
[21] M. Bañobre-López, Y. Piñeiro-Redondo, M. Sandri, A. Tampieri, R. De Santis, V.
A. Dediu, J. Rivas, Hyperthermia induced in magnetic scaffolds for bone tissue
engineering, IEEE Trans. Magn. 50 (11) (2014) 5400507–5400514.
[22] D.W. Urry, T.L. Trapane, K.U. Prasad, Phase-structure transitions of the elastin
polypentapeptide–water system within the framework of composition–
temperature studies, Biopolymers 24 (1985) 2345–2356.
[23] J.C. Rodrı´guez-Cabello, M. Alonso, T. Pérez, M.M. Herguedas, Differential
scanning calorimetry study of the hydrophobic hydration of the elastin-based
polypentapeptide, poly(VPGVG), from deficiency to excess of water,
Biopolymers 54 (2000) 282–288.
[24] A. Chilkoti, T. Christensen, J.A. MacKay, Stimulus responsive elastin
biopolymers: applications in medicine and biotechnology, Curr. Opin. Chem.
Biol. 10 (2006) 652–657.
[25] C.-H. Luan, D.W. Wry, Solvent deuteration enhancement of hydrophobicity:
DSC study of the inverse temperature transition of elastin-based polypeptide,
J. Phys. Chem. 95 (1991) 7896–7900.
[26] C.H. Luan, R.D. Harris, K.U. Prasad, D.W. Urry, Differential scanning calorimetry
studies of the inverse transition of the polypentapeptide of elastin and its
analogues, Biopolymers 29 (1990) 1699–1706.
[27] A. White, S. Jiang, Local and bulk hydration of zwitterionic glycine and its
analogues through molecular simulations, J. Phys. Chem. B 115 (2011) 660–
667.
[28] S.S.R.K. Challa, M. Faruq, Magnetic nanomaterials for hyperthermia-based
therapy and controlled drug delivery, Adv. Drug Deliv. Rev. 63 (2011) 789–
808.
[29] S.K. Samal, M. Dash, S. Shelyakova, A. Heidi, H.A. Declercq, M. Uhlarz, M.
Bañobre-López, P. Dubruel, M. Cornelissen, T. Herrmannsdörfer, J. Rivas, G.
Padeletti, S. De Smedt, K. Braeckmans, D.L. Kaplan, V.A. Dediu, Biomimetic
magnetic silk scaffolds, ACS Appl. Mater. Interfaces 7 (11) (2015) 6282–6292.
[30] Y. Piñeiro-Redondo, M. Bañobre-López, I. Pardiñas-Blanco, G. Goya, M.A.
López-Quintela, J. Rivas, The influence of colloidal parameters on the specific
power absorption of PAA-coated magnetite nanoparticles, Nanoscale Res. Lett.
6 (2011) 383.
